Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Evode takeover lifts Laporte through period of flat trade

Robert Cole
Wednesday 09 March 1994 00:02 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

KEN MINTON, chairman of the chemicals company Laporte, admitted yesterday that underlying trade in established operations was flat last year.

The acquisition of Evode, the glues manufacturer, meant Laporte's overall profit figures rose considerably. However, if Evode's contribution and flattering exchange rates are discounted, sales and profits were unchanged.

Group profit before tax increased 24 per cent to pounds 107m for the 12 months to 2 January.

Total operating profits grew by pounds 38m to pounds 116m. However, acquired companies added pounds 33m and currency movements another pounds 5m.

Mr Minton said yesterday: 'The core businesses performed solidly despite difficult trading conditions.' He added: 'We have successfully integrated the Evode businesses as promised at the time of the acquisition.'

Over the past 15 years Laporte has transformed itself from a handler of commodity chemicals to a speciality producer. It now supplies a vast range of companies from pharmaceutical manufacturers to makers of industrial cleaning fluids. The more specialised nature of the business gives Laporte wider profit margins.

Profit margins across the group last year declined from 14.8 to 13.2 per cent. Mr Minton said the drop was due to the incorporation of Evode. Action by Laporte, he said, expanded margins on the newly acquired rival from 4 to 11 per cent.

Most of the margin enhancement has come through cost-cutting. Staff levels were reduced by 25 per cent. Laporte set aside pounds 25m to cover the cost of integrating Evode. About half was spent writing down the value of assets acquired. Of the pounds 12m provided for the rationalisation of operations, Laporte has spent pounds 7m.

Rules covering accounting of acquisitions mean rationalisation costs can be incurred without affecting profits. Laporte spent pounds 250m on Evode in a mixture of cash and shares. But despite increasing the number of shares in issue, earnings per share rose by 6 per cent to 41.4p. In a falling market, Laporte shares closed down 20p at 794p.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in